How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-100
SponsorGeisinger Clinic
About this trial
This study is to see Osteopathic Manipulative Therapy, or OMT, can aid in treating patients being seen for respiratory illness and associated symptoms. The hypothesis is that the addition of OMT therapy, alongside other standard care (such as a medication), can help lessen patient symptoms sooner than just other treatment alone, and the duration of the condition will shorten as well.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients being seen for respiratory illness symptoms at Geisinger 65-Forward Buckhorn, PA clinic for care.
Patients age of 65-100
New diagnosis of upper respiratory illness, sinusitis, bronchitis, or pneumonia during outpatient visit.
Disqualifiers
Patients that have a healing fracture, including the spine, pelvis, shoulder, ribs, vertebrae, or extremities.
Patients actively receiving any type of cancer treatment
Patients with active or previously diagnosed liver disease.
Trial design
Design model
Parallel
Treatments tested in this trial
Lymphatic Pump Osteopathic Manipulative Therapy
Procedure/SurgeryOMT is a series of manual pressure and physical stimulation among various parts of the body to stimulate fluid movement and immune response in patients with various symptoms and disease. This may help with conditions such as edema, clearance of infections, facilitate healing and circulation, and bolster the immune response. Specifically, the lymphatic pump type of OMT targets the head, neck, thoracic region, lumbar and sacral regions, pelvis, arms, legs, and abdomen.
Treatment groups
68 Participants
are divided into 2 treatment groupsGroup A: ControlNo intervention 0 interventions
Group B: TreatmentExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
To address the magnitude in which lymphatic pump OMT improves respiratory illness symptom severity and overall sickness duration when combined with standard care treatment.
Survey given to patients will provide feedback to capture their symptom severity at the time of diagnosis and 5 days post-diagnosis
Time frame
Through study completion of up to one year.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov